Specificity of the Immune Response to a Modified Group B Meningococcal Polysaccharide Conjugate Vaccine

E. K. Farley,F. Michon,Samuel L. Moore,Peter C Fusco
DOI: https://doi.org/10.1128/CVI.00216-06
2006-11-01
Clinical and Vaccine Immunology
Abstract:ABSTRACT Antibodies to a modified group B meningococcal polysaccharide vaccine were examined for antigenic and functional specificities. Bactericidal determinants were investigated by using immunoaffinity columns and competitive inhibition of bactericidal activity in an in vitro killing assay. We conclude that nearly all of the vaccine-induced bactericidal activity is specific for the native polysaccharide.
Medicine,Biology
What problem does this paper attempt to address?